Hyaluronic acid products sales will expand through 2036, with single cycle injection products at 54.7% within the product segment in 2026. The market was valued at USD 9.43 billion in 2025, is projected to reach USD 16.82 billion by 2036 and is forecast to record a 5.4% CAGR between 2026 and 2036.